Physician profile
Alan Chalil
NPI 1013617687
$12,138.39
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $7,948 · 2024: $4,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $6,750 · Travel and Lodging: $3,056 · Food and Beverage: $2,332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $6,750.00 |
| Travel and Lodging | $3,056.49 |
| Food and Beverage | $2,331.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,750.00 | 2023 | |
| Neuropace, INC. | $2,100.56 | 2023-2024 | |
| Zimmer Biomet Holdings, INC. | $1,014.65 | 2024 | Cep, Rosa |
| Dixi Medical USA Corp | $980.82 | 2023 | |
| Boston Scientific Corporation | $909.92 | 2024 | Vercise |
| Stryker Corporation | $175.07 | 2024 | Insignia |
| Biotronik Nro, INC. | $121.94 | 2024 | Prospera |
| Clearpoint Neuro, INC. | $85.43 | 2023 | Clearpoint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Chalil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.